Alyeska Investment Group
ALIM

Alyeska Investment Group’s Alimera Sciences ALIM Stock Holding History

Alyeska Investment Group’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-67,593
Closed -$1.09M – 567
2016
Q4 		$1.09M Buy
67,593
+539
+0.8% +$9.87K 0.01% 421
2016
Q3 		$1.5M Buy
+67,054
New +$1.54M 0.01% 400
2014
Q3 		– Sell
-5,667
Closed -$508K – 471
2014
Q2 		$508K Sell
5,667
-9,750
-63% -$866K 0.01% 377
2014
Q1 		$1.82M Buy
+15,417
New +$1.5M 0.05% 268

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alyeska Investment Group's ALIM Position: Q1 2017 in Review

Alyeska Investment Group sold out of Alimera Sciences (ALIM) in Q1 2017, closing a stake of 67,593 shares — an estimated $1.09M sold.

Alyeska Investment Group first reported a position in ALIM in Q1 2014 and held it in 4 quarters. The position peaked at $1.82M in Q1 2014. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2017.

  • Alyeska Investment Group reported no remaining Alimera Sciences position as of Q1 2017 after selling out during the quarter.
  • Alyeska Investment Group sold 67,593 Alimera Sciences shares in Q1 2017, an estimated $1.09M.
  • Alyeska Investment Group first reported a position in Alimera Sciences in Q1 2014 and held it in 4 quarters.
  • Alyeska Investment Group's Alimera Sciences position peaked at $1.82M in Q1 2014.
  • 39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2017.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.